ProAssurance Co. (NYSE:PRA) Stock Holdings Raised by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership boosted its position in ProAssurance Co. (NYSE:PRA - Free Report) by 92.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 690,871 shares of the insurance provider's stock after acquiring an additional 331,224 shares during the period. Arrowstreet Capital Limited Partnership owned about 1.35% of ProAssurance worth $10,992,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PRA. Rhumbline Advisers grew its stake in shares of ProAssurance by 0.8% during the 4th quarter. Rhumbline Advisers now owns 160,707 shares of the insurance provider's stock valued at $2,557,000 after buying an additional 1,281 shares during the period. KBC Group NV grew its stake in shares of ProAssurance by 75.4% during the 4th quarter. KBC Group NV now owns 4,184 shares of the insurance provider's stock valued at $67,000 after buying an additional 1,798 shares during the period. New York State Teachers Retirement System grew its stake in shares of ProAssurance by 2.2% during the 4th quarter. New York State Teachers Retirement System now owns 89,326 shares of the insurance provider's stock valued at $1,421,000 after buying an additional 1,937 shares during the period. BNP Paribas Financial Markets grew its stake in shares of ProAssurance by 30.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 17,978 shares of the insurance provider's stock valued at $270,000 after buying an additional 4,149 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of ProAssurance by 0.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,316,249 shares of the insurance provider's stock valued at $20,678,000 after buying an additional 4,814 shares during the period. 85.58% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on PRA shares. Citigroup lowered shares of ProAssurance to a "market perform" rating in a report on Thursday, April 3rd. Raymond James lowered shares of ProAssurance from a "market perform" rating to an "underperform" rating in a report on Thursday. StockNews.com started coverage on shares of ProAssurance in a report on Wednesday. They set a "hold" rating on the stock. Finally, Citizens Jmp lowered shares of ProAssurance from an "outperform" rating to a "market perform" rating in a report on Thursday, April 3rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, ProAssurance presently has a consensus rating of "Hold" and a consensus price target of $18.67.

ProAssurance Stock Up 0.0 %

PRA stock traded up $0.01 during trading on Thursday, reaching $23.18. The stock had a trading volume of 182,547 shares, compared to its average volume of 735,911. ProAssurance Co. has a 1-year low of $10.76 and a 1-year high of $23.70. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $1.19 billion, a P/E ratio of 27.93 and a beta of -0.09. The firm has a fifty day moving average price of $17.87 and a 200 day moving average price of $16.43.

ProAssurance (NYSE:PRA - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.19. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The firm had revenue of $287.52 million for the quarter, compared to analyst estimates of $274.56 million. On average, equities analysts anticipate that ProAssurance Co. will post 0.8 earnings per share for the current year.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.